Gynecologic Cancers | Oncology Today with Dr Neil Love: Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers
Featuring a discussion on the current and future role of immune
checkpoint inhibitors and other novel therapies in the management
of gynecologic cancers with Dr David O’Malley, including the
following topics:
Current and Future Role of Immune Checkpoint Inhibitors and
Other Novel Therapies in the Management of Gynecologic Cancers —
David M O’Malley, MD (0:00)
Case: A woman in her late 20s with metastatic cervical cancer
treated with tisotumab vedotin (21:45)
Case: A woman in her mid-50s with metastatic cervical cancer
treated with balstilimab on a clinical trial (25:20)
Case: A woman in her 70s with MSI-high recurrent uterine cancer
(26:06)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.